A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA

Part of paid clinical trials in Phoenix, Arizona.

Sponsor
Ascendis Pharma Endocrinology Division A/S
Study ID
NCT05820672
Status
Recruiting

Conditions

  • Growth Hormone Deficiency

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • No intervention — OTHER
    No intervention

Study Details

The goal of this study is to genrate evidence on long-term effectiveness and safety of SKYTROFA (lonapegsomatropin) in patients with growth hormone deficiency under routine clinical care

Key Dates

Start date
Mar 20, 2023
Status verified
Apr 2026
Primary completion
Mar 31, 2033
Completion
Mar 31, 2033

Study Design

Enrollment
900 participants (estimated)

Arms

  • Arm: Patients on SKYTROFA Treatment
    Patients on SKYTROFA Treatment managed in USA with appropriate written Informed Consent

Primary Outcome Measure

Assess the safety of patients treated with SKYTROFA (Lonapegsomatropin) [ Time Frame: 5 years ]

Central Contacts

Locations (27)

FacilityCityStateZIPSite coordinators
Ascendis Investigational SitePhoenixArizona85054-
Ascendis Investigational SiteOrangeCalifornia92868-
Ascendis Investigational SiteSacramentoCalifornia95821-
Ascendis Investigational SiteSan FranciscoCalifornia94143-
Ascendis Pharma Investigational SiteCentennialColorado80112-
Ascendis Investigational SiteWashington D.C.District of Columbia20010-
Ascendis Investigational SiteOrlandoFlorida32806-
Ascendis Investigational SiteOrlandoFlorida32827-
Ascendis Investigational SiteTampaFlorida33612-
Ascendis Investigational SiteSandy SpringsGeorgia30350-
Ascendis Investigational SiteBoiseIdaho83712-
Ascendis Investigational SiteIndianapolisIndiana46202-
Ascendis Investigational SiteIowa CityIowa52242-
Ascendis Investigational SiteLouisvilleKentucky40202-
Ascendis Investigational SiteMinneapolisMinnesota55455-
Ascendis Investigational SiteLas VegasNevada89113-
Ascendis Investigational SiteLebanonNew Hampshire03756-
Ascendis Investigational SiteManchesterNew Hampshire03104-
Ascendis Investigational SiteMorristownNew Jersey07960-
Ascendis Investigational SiteNew Hyde ParkNew York11042-
Ascendis Investigational SiteCincinnatiOhio45229-
Ascendis Investigational SitePortlandOregon97239-
Ascendis Investigational SiteColumbiaSouth Carolina29203-
Ascendis Investigational SiteDallasTexas75390-
Ascendis Investigational SiteEl PasoTexas79907-
Ascendis Investigational SiteNorfolkVirginia23507-
Ascendis Investigational SiteSeattleWashington98105-

Find similar trials in Phoenix, AZ

Related Studies